3-49488867-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_004393.6(DAG1):​c.-117+18434C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.418 in 151,398 control chromosomes in the GnomAD database, including 14,865 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.42 ( 14865 hom., cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

DAG1
NM_004393.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.934

Publications

8 publications found
Variant links:
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
DAG1 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2P
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated asymptomatic elevation of creatine phosphokinase
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 3-49488867-C-T is Benign according to our data. Variant chr3-49488867-C-T is described in ClinVar as [Benign]. Clinvar id is 1251824.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.908 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DAG1NM_004393.6 linkc.-117+18434C>T intron_variant Intron 1 of 2 ENST00000308775.7 NP_004384.5 Q14118A0A024R2W4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DAG1ENST00000308775.7 linkc.-117+18434C>T intron_variant Intron 1 of 2 1 NM_004393.6 ENSP00000312435.2 Q14118

Frequencies

GnomAD3 genomes
AF:
0.418
AC:
63270
AN:
151278
Hom.:
14855
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.272
Gnomad AMI
AF:
0.535
Gnomad AMR
AF:
0.572
Gnomad ASJ
AF:
0.344
Gnomad EAS
AF:
0.930
Gnomad SAS
AF:
0.681
Gnomad FIN
AF:
0.351
Gnomad MID
AF:
0.389
Gnomad NFE
AF:
0.427
Gnomad OTH
AF:
0.421
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
4
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
4
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.418
AC:
63298
AN:
151398
Hom.:
14865
Cov.:
31
AF XY:
0.424
AC XY:
31369
AN XY:
73958
show subpopulations
African (AFR)
AF:
0.272
AC:
11205
AN:
41258
American (AMR)
AF:
0.573
AC:
8705
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.344
AC:
1191
AN:
3466
East Asian (EAS)
AF:
0.930
AC:
4809
AN:
5170
South Asian (SAS)
AF:
0.680
AC:
3267
AN:
4804
European-Finnish (FIN)
AF:
0.351
AC:
3640
AN:
10376
Middle Eastern (MID)
AF:
0.388
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
0.427
AC:
28983
AN:
67816
Other (OTH)
AF:
0.427
AC:
900
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1722
3444
5165
6887
8609
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.412
Hom.:
2218
Bravo
AF:
0.428

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.21
DANN
Benign
0.49
PhyloP100
-0.93
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4855859; hg19: chr3-49526300; API